東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

Drug targets for plasmodium falciparum = historic to future perspectives /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Drug targets for plasmodium falciparum/ by Mohammed Tarique.
其他題名:	historic to future perspectives /
作者:	Tarique, Mohammed.
出版者:	Singapore :Springer Nature Singapore : : 2024.,
面頁冊數:	xiii, 199 p. :ill. (chiefly col.), digital ;24 cm.
內容註:	Chapter 1. Introduction: An overview of Malaria and Plasmodium -- Chapter 2. Pathogenesis of Plasmodium falciparum -- Chapter 3. Antimalarial Drugs and drug resistance -- Chapter 4. Metabolic pathways of Enzymes: Therapeutic targets and prospects for Innovative antimalarial drugs -- Chapter 5. Targeting apicoplasts in Plasmodium falciparum, origin and pathways -- Chapter 6. Proteases and protein kinases as potential drug target -- Chapter 7. Plasmodium falciparum: Transporter and Drug Target -- Chapter 8. Enzymes of isoprenoid biosynthesis and control of malarial parasite plasmodium falciparum -- Chapter 9.Ubiquitin-Proteasome system as a potential drug target for Malaria -- Chapter 10.Food Vacuole as a Drug Target.
Contained By:	Springer Nature eBook
標題:	Malaria - Treatment. -
電子資源:	https://doi.org/10.1007/978-981-19-4484-0
ISBN:	9789811944840

Drug targets for plasmodium falciparum = historic to future perspectives /
Tarique, Mohammed.

Drug targets for plasmodium falciparumhistoric to future perspectives /[electronic resource] :by Mohammed Tarique. - Singapore :Springer Nature Singapore :2024. - xiii, 199 p. :ill. (chiefly col.), digital ;24 cm.

Chapter 1. Introduction: An overview of Malaria and Plasmodium -- Chapter 2. Pathogenesis of Plasmodium falciparum -- Chapter 3. Antimalarial Drugs and drug resistance -- Chapter 4. Metabolic pathways of Enzymes: Therapeutic targets and prospects for Innovative antimalarial drugs -- Chapter 5. Targeting apicoplasts in Plasmodium falciparum, origin and pathways -- Chapter 6. Proteases and protein kinases as potential drug target -- Chapter 7. Plasmodium falciparum: Transporter and Drug Target -- Chapter 8. Enzymes of isoprenoid biosynthesis and control of malarial parasite plasmodium falciparum -- Chapter 9.Ubiquitin-Proteasome system as a potential drug target for Malaria -- Chapter 10.Food Vacuole as a Drug Target.

This book offers a comprehensive exploration of malaria, a life-threatening disease affecting millions globally, with a focus on the parasitic organisms of the genus Plasmodium that cause it. It discusses the challenges posed by the disease, especially in economically developing regions, and delves into the biology and pathophysiology of the Plasmodium species, including their genetic flexibility and resistance to treatments. Special attention is given to P. falciparum, the most dangerous of these parasites, detailing its complex life cycle, interaction with human hosts, and the severe clinical manifestations it can induce. The book further explores the global health concern of antimalarial drug resistance, highlighting the WHO's efforts in combating the disease and the necessity for novel treatments. Innovative research directions, such as targeting the unique organelles of Plasmodium like the apicoplast and employing proteasome inhibitors, are thoroughly examined as potential strategies in the development of new antimalarial drugs. Additionally, it addresses the critical role of the hemoglobin digestion process in the parasite's lifecycle, presenting it as a promising target for therapeutic intervention. This work is an essential resource for researchers, clinicians, and policymakers involved in malaria control and drug development, providing insights into the current challenges and future directions in the fight against this endemic disease.

ISBN: 9789811944840

Standard No.: 10.1007/978-981-19-4484-0doiSubjects--Topical Terms:

3718422
Malaria
--Treatment.

LC Class. No.: QR201.M3

Dewey Class. No.: 616.9362

Drug targets for plasmodium falciparum = historic to future perspectives /
LDR:03213nmm a2200325 a 4500 001 2371992
003 DE-He213
005 20240619103828.0
006 m d
007 cr nn 008maaau
008 241127s2024 si s 0 eng d
020 $a 9789811944840 $q (electronic bk.)
020 $a 9789811944833 $q (paper)
024 7 $a 10.1007/978-981-19-4484-0 $2 doi
035 $a 978-981-19-4484-0
040 $a GP $c GP
041 0 $a eng
050 4 $a QR201.M3
072 7 $a PSGH $2 bicssc
072 7 $a SCI045000 $2 bisacsh
072 7 $a PSG $2 thema
082 0 4 $a 616.9362 $2 23
090 $a QR201.M3 $b T187 2024
100 1 $a Tarique, Mohammed. $3 3504827
245 1 0 $a Drug targets for plasmodium falciparum $h [electronic resource] : $b historic to future perspectives / $c by Mohammed Tarique.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2024.
300 $a xiii, 199 p. : $b ill. (chiefly col.), digital ; $c 24 cm.
505 0 $a Chapter 1. Introduction: An overview of Malaria and Plasmodium -- Chapter 2. Pathogenesis of Plasmodium falciparum -- Chapter 3. Antimalarial Drugs and drug resistance -- Chapter 4. Metabolic pathways of Enzymes: Therapeutic targets and prospects for Innovative antimalarial drugs -- Chapter 5. Targeting apicoplasts in Plasmodium falciparum, origin and pathways -- Chapter 6. Proteases and protein kinases as potential drug target -- Chapter 7. Plasmodium falciparum: Transporter and Drug Target -- Chapter 8. Enzymes of isoprenoid biosynthesis and control of malarial parasite plasmodium falciparum -- Chapter 9.Ubiquitin-Proteasome system as a potential drug target for Malaria -- Chapter 10.Food Vacuole as a Drug Target.
520 $a This book offers a comprehensive exploration of malaria, a life-threatening disease affecting millions globally, with a focus on the parasitic organisms of the genus Plasmodium that cause it. It discusses the challenges posed by the disease, especially in economically developing regions, and delves into the biology and pathophysiology of the Plasmodium species, including their genetic flexibility and resistance to treatments. Special attention is given to P. falciparum, the most dangerous of these parasites, detailing its complex life cycle, interaction with human hosts, and the severe clinical manifestations it can induce. The book further explores the global health concern of antimalarial drug resistance, highlighting the WHO's efforts in combating the disease and the necessity for novel treatments. Innovative research directions, such as targeting the unique organelles of Plasmodium like the apicoplast and employing proteasome inhibitors, are thoroughly examined as potential strategies in the development of new antimalarial drugs. Additionally, it addresses the critical role of the hemoglobin digestion process in the parasite's lifecycle, presenting it as a promising target for therapeutic intervention. This work is an essential resource for researchers, clinicians, and policymakers involved in malaria control and drug development, providing insights into the current challenges and future directions in the fight against this endemic disease.
650 0 $a Malaria $x Treatment. $3 3718422
650 0 $a Antimalarials. $3 895439
650 0 $a Drug resistance in microorganisms. $3 669099
650 0 $a Plasmodium falciparum. $3 2016936
650 1 4 $a Parasitology. $3 635062
650 2 4 $a Proteins. $3 558769
650 2 4 $a Pathogenesis. $3 3561735
650 2 4 $a Pharmacology. $3 634543
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-19-4484-0
950 $a Biomedical and Life Sciences (SpringerNature-11642)